Skip to main content
Log in

Anxiety as Predictor of the Cortisol Awakening Response in Patients with Coronary Heart Disease

  • Published:
International Journal of Behavioral Medicine Aims and scope Submit manuscript

Abstract

Background

Anxiety is associated with worse outcomes in patients with coronary heart disease (CHD). A dysregulation of the HPA axis is a potential mechanism linking psychological factors and coronary disease. No study has yet investigated the relationship between anxiety and cortisol among patients with established CHD.

Purpose

The aim of this study was to assess the association between anxiety and the cortisol awakening response in patients with CHD.

Method

Four salivary cortisol samples were used to assess two measures of the cortisol awakening response (CAR) in 47 patients with established CHD. Anxiety was measured using the Hospital Anxiety and Depression Scale (HADS).

Results

Higher anxiety values were associated with a higher total output of cortisol in the first hour after awakening (AUCg, area under the curve with respect to ground) (p = 0.04) and a nonsignificant trend towards a more pronounced increase (AUCi, area under the curve with respect to increase) (p = 0.08). In patients who had a history of myocardial infarction (MI), the cortisol output was lower compared to patients who had no previous MI (p = 0.02). In linear regression analyses, anxiety emerged as significant predictor of AUCg and AUCi after controlling for MI, ejection fraction (LVEF, left ventricular ejection fraction), and depression.

Conclusions

Our results provide further indications for an association between anxiety and a dysregulation of the HPA axis. History of MI emerged as second predictor of cortisol output in the morning.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Notes

  1. The correlation between AUCi and CAR values (computed by subtracting the baseline cortisol values from the values at +30 min) was r = 0.94, p = 0.000.

References

  1. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99:2192–217.

    Article  PubMed  CAS  Google Scholar 

  2. Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010;56:38–46.

    Article  PubMed  Google Scholar 

  3. Roest AM, Martens EJ, Denollet J, de Jonge P. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med. 2010;72:563–9.

    Article  PubMed  Google Scholar 

  4. Girod JP, Brotman DJ. Does altered glucocorticoid homeostasis increase cardiovascular risk? Cardiovasc Res. 2004;64:217–26.

    Article  PubMed  CAS  Google Scholar 

  5. von Känel R, Mausbach BT, Kudielka BM, Orth-Gomér K. Relation of morning serum cortisol to prothrombotic activity in women with stable coronary artery disease. J Thromb Thrombolysis. 2008;25:165–72.

    Article  Google Scholar 

  6. Rosmond R, Björntorp P. The hypothalamic–pituitary–adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med. 2000;247:188–97.

    Article  PubMed  CAS  Google Scholar 

  7. Kudielka BM, Kirschbaum C. Awakening cortisol responses are influenced by health status and awakening time but not by menstrual cycle phase. Psychoneuroendocrinology. 2003;28:35–47.

    Article  PubMed  CAS  Google Scholar 

  8. Vreeburg SA, Kruijtzer BP, van Pelt J, van Dyck R, DeRijk RH, Hoogendijk WJ, Smit JH, Zitman FG, Penninx BW. Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology. Psychoneuroendocrinology. 2009;34:1109–20.

    Article  PubMed  CAS  Google Scholar 

  9. Troxler RG, Sprague EA, Albanese RA, Fuchs R, Thompson AJ. The association of elevated plasma cortisol and early atherosclerosis as demonstrated by coronary angiography. Atherosclerosis. 1977;26:151–62.

    Article  PubMed  CAS  Google Scholar 

  10. Matthews K, Schwartz J, Cohen S, Seeman T. Diurnal cortisol decline is related to coronary calcification: CARDIA study. Psychosom Med. 2006;68:657–61.

    Article  PubMed  CAS  Google Scholar 

  11. Nijm J, Kristenson M, Olsson AG, Jonasson L. Impaired cortisol response to acute stressors in patients with coronary disease. Implications for inflammatory activity. J Intern Med. 2007;262:375–84.

    Article  PubMed  CAS  Google Scholar 

  12. Dekker MJ, Koper JW, van Aken MO, Pols HA, Hofman A, de Jong FH, Kirschbaum C, Witteman JC, Lamberts SW, Tiemeier H. Salivary cortisol is related to atherosclerosis of carotid arteries. J Clin Endocrinol Metab. 2008;93:3741–7.

    Article  PubMed  CAS  Google Scholar 

  13. Davey Smith G, Ben-Shlomo Y, Beswick A, Yarnell J, Lightman S, Elwood P. Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation. 2005;112:332–40.

    Article  Google Scholar 

  14. Sjögren E, Leanderson P, Kristenson M. Diurnal saliva cortisol levels and relations to psychosocial factors in a population sample of middle-aged Swedish men and women. Int J Behav Med. 2006;13:193–200.

    Article  PubMed  Google Scholar 

  15. Kristenson M, Orth-Gomér M, Kucinskienë Z, Bergdahl B, Calkauskas H, Balinkyniene I, Olsson AG. Attenuated cortisol response to a standardized stress test in Lithuanian versus Swedish men: the LiVicordia study. Int J Behav Med. 1998;5:17–30.

    Article  PubMed  CAS  Google Scholar 

  16. Vreeburg SA, Zitman FS, van Pelt J, Derijk RH, Verhagen JCM, van Dyck R, Hoogendijk WJG, Smit JH, Penninx BWJH. Salivary cortisol levels in persons with and without different anxiety disorders. Psychosom Med. 2010;72:340–7.

    Article  PubMed  CAS  Google Scholar 

  17. Mantella RC, Butters MA, Amico JA, Mazumdar S, Rollman BL, Begley AE, Reynolds CF, Lenze EJ. Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder. Psychoneuroendocrinology. 2008;33:773–81.

    Article  PubMed  CAS  Google Scholar 

  18. Bhattacharyya MR, Molloy GJ, Steptoe A. Depression is associated with flatter cortisol rhythms in patients with coronary artery disease. J Psychosom Res. 2008;65:107–13.

    Article  PubMed  Google Scholar 

  19. Otte C, Marmar CR, Pipkin SS, Moos R, Browner WS, Whooley MA. Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: the Heart and Soul Study. Biol Psychiatry. 2004;56:241–7.

    Article  PubMed  CAS  Google Scholar 

  20. Molloy GJ, Perkins-Porras L, Strike PC, Steptoe A. Type-D personality and cortisol in survivors of acute coronary syndrome. Psychosom Med. 2008;70:863–8.

    Article  PubMed  CAS  Google Scholar 

  21. Whitehead DL, Perkins-Porras L, Strike PC, Magid K, Steptoe A. Cortisol awakening response is elevated in acute coronary syndrome patients with type-D personality. J Psychosom Res. 2007;62:419–25.

    Article  PubMed  Google Scholar 

  22. Fries E, Dettenborn L, Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int J Psychophysiol. 2009;72:67–73.

    Article  PubMed  Google Scholar 

  23. Merswolken M, Siebenhuener S, Orth-Gomér K, Zimmermann-Viehoff F, Deter HC. Treating anxiety in patients with coronary heart disease—a randomized controlled trial. Psychother Psychosom. 2011;80:365–70.

    Article  PubMed  Google Scholar 

  24. Herrmann C, Buss U, Snaith RP. HADS-D—hospital anxiety and depression scale—Deutsche version. Bern: Huber; 1995.

    Google Scholar 

  25. Herrmann C. International experiences with the hospital anxiety and depression scale—a review of validation data and clinical results. J Psychosom Res. 1997;42:17–41.

    Article  PubMed  CAS  Google Scholar 

  26. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52:69–77.

    Article  PubMed  Google Scholar 

  27. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology. 2003;28:916–31.

    Article  PubMed  CAS  Google Scholar 

  28. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.

    Article  PubMed  CAS  Google Scholar 

  29. Naqvi TZ, Naqvi SS, Merz CN. Gender differences in the link between depression and cardiovascular disease. Psychosom Med. 2005;67:15–8.

    Article  Google Scholar 

  30. Ströhle A, Holsboer F. Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry. 2003;36:207–14.

    Google Scholar 

  31. Hauner H, Bognar E, Blum A. Body fat distribution and its association with metabolic and hormonal risk factors in women with angiographically assessed coronary artery disease: evidence for the presence of a metabolic syndrome. Atherosclerosis. 1994;105:209–16.

    Article  PubMed  CAS  Google Scholar 

  32. Schwertner H, Troxler R, Uhl G, Jackson WG. Relationship between cortisol and cholesterol in men with coronary artery disease and type A behavior. Arterioscler Thromb Vasc Biol. 1984;4:59–64.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Melanie Merswolken.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Merswolken, M., Deter, HC., Siebenhuener, S. et al. Anxiety as Predictor of the Cortisol Awakening Response in Patients with Coronary Heart Disease. Int.J. Behav. Med. 20, 461–467 (2013). https://doi.org/10.1007/s12529-012-9233-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12529-012-9233-6

Keywords

Navigation